Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: Jul 6, 2021
Date Accepted: Oct 7, 2021
Date Submitted to PubMed: Aug 26, 2023

The final, peer-reviewed published version of this preprint can be found here:

From the Cochrane Library: Topical Tacrolimus for Atopic Dermatitis

Hamp A, Anderson J, Sivesind T, Cury-Martins J

From the Cochrane Library: Topical Tacrolimus for Atopic Dermatitis

JMIR Dermatol 2021;4(2):e31838

DOI: 10.2196/31838

PMID: 37632863

PMCID: 10334957

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

From the Cochrane Library: Topical tacrolimus for atopic dermatitis

  • Austin Hamp; 
  • Jarett Anderson; 
  • Torunn Sivesind; 
  • Jade Cury-Martins

ABSTRACT

---


 Citation

Please cite as:

Hamp A, Anderson J, Sivesind T, Cury-Martins J

From the Cochrane Library: Topical Tacrolimus for Atopic Dermatitis

JMIR Dermatol 2021;4(2):e31838

DOI: 10.2196/31838

PMID: 37632863

PMCID: 10334957

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.